Skip to content
Back to Guavy Wire
Stocks

AI Model RetroChimera Speeds Up Molecule Synthesis with High Accuracy

Instruments
MSFT
Share

Researchers from Microsoft Research and collaborators have developed an AI model called RetroChimera to help automate the process of molecule synthesis. The system, described in a study published in Nature, uses multiple models with complementary strengths to propose promising synthesis pathways for target molecules.

The development of RetroChimera builds on Microsoft's longstanding research into using AI to accelerate scientific discovery, including advances in chemistry and drug development. The researchers analyzed common shortcomings in existing retrosynthesis systems, including difficulties incorporating less frequent but strategically important reactions and a tendency to generate inaccurate predictions.

According to the study, RetroChimera was able to propose fully accepted sequences of reactions for nine molecules selected to benchmark its performance against other models. When expert chemists evaluated proposed pathways for these molecules, they preferred RetroChimera's approach about 64% of the time.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc